Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Study to Evaluate the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder
A Study to Preliminarily Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder
Status: Enrolling
Updated:  10/20/2017
Clinical Research Facility
mi
from
Toms River, NJ
Study to Evaluate the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder
A Study to Preliminarily Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder
Status: Enrolling
Updated: 10/20/2017
Clinical Research Facility
mi
from
Toms River, NJ
Click here to add this to my saved trials
Study to Evaluate the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder
A Study to Preliminarily Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder
Status: Enrolling
Updated:  10/20/2017
Clinical Research Facility
mi
from
Durham, NC
Study to Evaluate the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder
A Study to Preliminarily Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder
Status: Enrolling
Updated: 10/20/2017
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Costa Mesa, CA
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Hamden, CT
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Hamden, CT
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Orlando, FL
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Tampa, FL
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
West Palm Beach, FL
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Atlanta, GA
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Easton, MD
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Easton, MD
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Flowood, MS
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Flowood, MS
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Toms River, NJ
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Toms River, NJ
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Staten Island, NY
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Staten Island, NY
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Hickory, NC
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Hickory, NC
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Portland, OR
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Norristown, PA
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Norristown, PA
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Austin, TX
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Bennington, VT
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Bennington, VT
Click here to add this to my saved trials
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from
Waukesha, WI
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from
Waukesha, WI
Click here to add this to my saved trials
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated:  10/23/2017
University of Alabama
mi
from
Birmingham, AL
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated: 10/23/2017
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated:  10/23/2017
Contra Costa Health Services (East and West Contra Costa)
mi
from
Martinez, CA
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated: 10/23/2017
Contra Costa Health Services (East and West Contra Costa)
mi
from
Martinez, CA
Click here to add this to my saved trials
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated:  10/23/2017
Southeast Health Center
mi
from
San Francisco, CA
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated: 10/23/2017
Southeast Health Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated:  10/23/2017
Santa Clara Health Center
mi
from
San Jose, CA
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated: 10/23/2017
Santa Clara Health Center
mi
from
San Jose, CA
Click here to add this to my saved trials
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated:  10/23/2017
Yale Primary Care Center
mi
from
New Haven, CT
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated: 10/23/2017
Yale Primary Care Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated:  10/23/2017
East Baltimore Medical Center
mi
from
Baltimore, MD
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated: 10/23/2017
East Baltimore Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated:  10/23/2017
Boston Healthcare for the Homeless Program
mi
from
Boston, MA
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated: 10/23/2017
Boston Healthcare for the Homeless Program
mi
from
Boston, MA
Click here to add this to my saved trials
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated:  10/23/2017
Montefiore Transition Clinic
mi
from
New York, NY
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated: 10/23/2017
Montefiore Transition Clinic
mi
from
New York, NY
Click here to add this to my saved trials
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated:  10/23/2017
Medicine in Psychiatry Service clinic of the University of Rochester Medical Center
mi
from
Rochester, NY
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated: 10/23/2017
Medicine in Psychiatry Service clinic of the University of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated:  10/23/2017
Corporacion SANOS
mi
from
Caguas,
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated: 10/23/2017
Corporacion SANOS
mi
from
Caguas,
Click here to add this to my saved trials
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated:  10/23/2017
Morningside Clinic
mi
from
New York, NY
Linking Former Inmates to Primary Care
Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care
Status: Enrolling
Updated: 10/23/2017
Morningside Clinic
mi
from
New York, NY
Click here to add this to my saved trials
A Transdiagnostic Sleep and Circadian Treatment to Improve Community SMI Outcomes
A Transdiagnostic Sleep and Circadian Treatment to Improve Community SMI Outcomes
Status: Enrolling
Updated:  10/23/2017
Alameda Country Behavioral Health Care Services
mi
from
Oakland, CA
A Transdiagnostic Sleep and Circadian Treatment to Improve Community SMI Outcomes
A Transdiagnostic Sleep and Circadian Treatment to Improve Community SMI Outcomes
Status: Enrolling
Updated: 10/23/2017
Alameda Country Behavioral Health Care Services
mi
from
Oakland, CA
Click here to add this to my saved trials
Main Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients
A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Electrocardiographic Effects of Lofexidine When Administered Orally to Methadone Maintained Adult Subjects
Status: Enrolling
Updated:  10/24/2017
Lifetree Clinical Research
mi
from
Salt Lake City, UT
Main Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients
A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Electrocardiographic Effects of Lofexidine When Administered Orally to Methadone Maintained Adult Subjects
Status: Enrolling
Updated: 10/24/2017
Lifetree Clinical Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
The Efficacy of Computerized Alcohol Screening and Intervention (CASI) in At-Risk Emergency Department and Trauma Patients
Status: Enrolling
Updated:  10/24/2017
Uc Irvine Medical Center
mi
from
Orange, CA
The Efficacy of Computerized Alcohol Screening and Intervention (CASI) in At-Risk Emergency Department and Trauma Patients
Status: Enrolling
Updated: 10/24/2017
Uc Irvine Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
The Effect of Computerized Alcohol Screening and Brief Intervention (CASI) on Alcohol Consumption in Adolescent Patients in the Emergency Department
Status: Enrolling
Updated:  10/24/2017
Uc Irvine Medical Center
mi
from
Orange, CA
The Effect of Computerized Alcohol Screening and Brief Intervention (CASI) on Alcohol Consumption in Adolescent Patients in the Emergency Department
Status: Enrolling
Updated: 10/24/2017
Uc Irvine Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
Delivery of Anxiety Disorder Treatment in Addictions Centers
Adaptation of CALM for Comorbid Anxiety and Substance Use Disorders
Status: Enrolling
Updated:  10/24/2017
Matrix Institute on Addictions
mi
from
Los Angeles, CA
Delivery of Anxiety Disorder Treatment in Addictions Centers
Adaptation of CALM for Comorbid Anxiety and Substance Use Disorders
Status: Enrolling
Updated: 10/24/2017
Matrix Institute on Addictions
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Delivery of Anxiety Disorder Treatment in Addictions Centers
Adaptation of CALM for Comorbid Anxiety and Substance Use Disorders
Status: Enrolling
Updated:  10/24/2017
University of California-Los Angeles, Department of Psychiatry and Biobehavioral Sciences
mi
from
Los Angeles, CA
Delivery of Anxiety Disorder Treatment in Addictions Centers
Adaptation of CALM for Comorbid Anxiety and Substance Use Disorders
Status: Enrolling
Updated: 10/24/2017
University of California-Los Angeles, Department of Psychiatry and Biobehavioral Sciences
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Online Response Inhibition Training for Trichotillomania
Developing Online Response Inhibition Training for Individuals With Trichotillomania
Status: Enrolling
Updated:  10/24/2017
UWM Anxiety Disorders Laboratory
mi
from
Milwaukee, WI
Online Response Inhibition Training for Trichotillomania
Developing Online Response Inhibition Training for Individuals With Trichotillomania
Status: Enrolling
Updated: 10/24/2017
UWM Anxiety Disorders Laboratory
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated:  10/24/2017
Clinical Research Facility
mi
from
Little Rock, AR
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated: 10/24/2017
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated:  10/24/2017
Clinical Research Facility
mi
from
Springdale, AR
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated: 10/24/2017
Clinical Research Facility
mi
from
Springdale, AR
Click here to add this to my saved trials
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated:  10/24/2017
Clinical Research Facility
mi
from
San Diego, CA
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated: 10/24/2017
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated:  10/24/2017
Clinical Research Facility
mi
from
Hollywood, FL
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated: 10/24/2017
Clinical Research Facility
mi
from
Hollywood, FL
Click here to add this to my saved trials
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated:  10/24/2017
Clinical Research Facility
mi
from
Orlando, FL
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated: 10/24/2017
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated:  10/24/2017
Clinical Research Facility
mi
from
Atlanta, GA
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated: 10/24/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated:  10/24/2017
Clinical Research Facility
mi
from
Winfield, IL
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated: 10/24/2017
Clinical Research Facility
mi
from
Winfield, IL
Click here to add this to my saved trials
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated:  10/24/2017
Clinical Research Facility
mi
from
Lake Charles, LA
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated: 10/24/2017
Clinical Research Facility
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated:  10/24/2017
Clinical Research Facility
mi
from
Rockville, MD
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated: 10/24/2017
Clinical Research Facility
mi
from
Rockville, MD
Click here to add this to my saved trials
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated:  10/24/2017
Clinical Research Facility
mi
from
Flowood, MS
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated: 10/24/2017
Clinical Research Facility
mi
from
Flowood, MS
Click here to add this to my saved trials
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated:  10/24/2017
Clinical Research Facility
mi
from
Dayton, OH
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated: 10/24/2017
Clinical Research Facility
mi
from
Dayton, OH
Click here to add this to my saved trials
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated:  10/24/2017
Clinical Research Facility
mi
from
Portland, OR
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated: 10/24/2017
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated:  10/24/2017
Clinical Research Facility
mi
from
Pittsburgh, PA
Open-Label, Safety Study of Lofexidine
A Phase 3, Open-Label, Safety Study of Lofexidine
Status: Enrolling
Updated: 10/24/2017
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials